{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidmvkviptlajpg3m5rkon37ygq76xlbggitq2y3i2qqc4uzowvc54",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnioolbo5an2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiabhmyt33cuc4sfernevlxc6ndien3obiemhkrfawqcj6q7bib6gi"
    },
    "mimeType": "image/jpeg",
    "size": 1283123
  },
  "path": "/news/2026-06-common-blood-pressure-medication-poorer.html",
  "publishedAt": "2026-06-04T18:10:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be associated with poorer kidney outcomes in people with type 2 diabetes (T2D), even among patients already receiving modern kidney-protective treatments.",
  "title": "Common blood pressure medication associated with poorer kidney outcomes in type 2 diabetes"
}